moxifloxacin has been researched along with desoxycorticosterone in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (desoxycorticosterone) | Trials (desoxycorticosterone) | Recent Studies (post-2010) (desoxycorticosterone) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 7,588 | 52 | 284 |
| Protein | Taxonomy | moxifloxacin (IC50) | desoxycorticosterone (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 3 | Rattus norvegicus (Norway rat) | 8.4 | |
| Solute carrier family 22 member 2 | Rattus norvegicus (Norway rat) | 1.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
1 other study(ies) available for moxifloxacin and desoxycorticosterone
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |